Barricade Therapeutics is a privately held biotech company.
Barricade Therapeutics has raised $337K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in March 2026.
Barricade Therapeutics's investors include Cancer Prevention and Research Institute of Texas.
Barricade Therapeutics is headquartered in Fort Worth, United States.
Barricade Therapeutics is a privately held biotech company.
Barricade Therapeutics is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Barricade Therapeutics — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/barricade-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Barricade Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/barricade-therapeutics
{{cite web |title=Barricade Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/barricade-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated